Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: the randomized, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)
Ettrich, Thomas J., Perkhofer, Lukas, Decker, Thomas, Hofheinz, Ralf-Dieter, Heinemann, Volker, Hoffmann, Thomas, Hebart, Holger F., Herrmann, Thomas, Hannig, Carla V., Büchner-Steudel, Petra, GüthlJournal:
International Journal of Cancer
DOI:
10.1002/ijc.33296
Date:
September, 2020
File:
PDF, 1.24 MB
2020